Goosehead Insurance, Inc. Class A Common Stock GSHD
i
Market dataready · fetched 2026-11-12T03:09:52.172Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T23:13:53.736464477Z
FundamentalsSEC EDGAR · ready · as of 2026-06-30 · fetched 2026-11-12T03:09:51.812494+00:00
Goosehead Insurance, Inc. Class A Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 57.40 | 144.2% | 26.6% | 40.18 | 118.8% | 15.2% |
| 25Δ | 54.13 | 128.9% | 20.0% | 41.42 | 109.7% | 12.9% |
| 30Δ | 51.76 | 113.5% | 15.1% | 42.65 | 100.6% | 10.7% |
| 35Δ | 49.76 | 100.9% | 11.2% | 43.88 | 91.5% | 8.5% |
| 40Δ | 48.85 | 95.8% | 9.7% | 45.07 | 83.2% | 6.4% |
| 45Δ | 47.94 | 90.8% | 8.3% | 45.83 | 82.1% | 5.7% |
| 50Δ | 47.03 | 85.7% | 6.8% | 46.58 | 81.0% | 5.0% |
| 55Δ | 46.12 | 80.7% | 5.3% | 47.34 | 79.9% | 4.3% |
| 60Δ | 45.20 | 75.6% | 3.9% | 48.09 | 78.9% | 3.6% |
| 65Δ | 44.24 | 76.6% | 3.1% | 48.85 | 77.8% | 2.9% |
| 70Δ | 43.26 | 79.3% | 2.7% | 49.60 | 76.7% | 2.2% |
| 75Δ | 42.28 | 82.1% | 2.2% | 50.53 | 75.1% | 1.6% |
| 80Δ | 41.29 | 84.8% | 1.7% | 51.67 | 73.0% | 1.2% |
20Δ
- Pseudo strike
- 57.40
- IV
- 144.2%
- B/E move
- 26.6%
- Pseudo strike
- 40.18
- IV
- 118.8%
- B/E move
- 15.2%
25Δ
- Pseudo strike
- 54.13
- IV
- 128.9%
- B/E move
- 20.0%
- Pseudo strike
- 41.42
- IV
- 109.7%
- B/E move
- 12.9%
30Δ
- Pseudo strike
- 51.76
- IV
- 113.5%
- B/E move
- 15.1%
- Pseudo strike
- 42.65
- IV
- 100.6%
- B/E move
- 10.7%
35Δ
- Pseudo strike
- 49.76
- IV
- 100.9%
- B/E move
- 11.2%
- Pseudo strike
- 43.88
- IV
- 91.5%
- B/E move
- 8.5%
40Δ
- Pseudo strike
- 48.85
- IV
- 95.8%
- B/E move
- 9.7%
- Pseudo strike
- 45.07
- IV
- 83.2%
- B/E move
- 6.4%
45Δ
- Pseudo strike
- 47.94
- IV
- 90.8%
- B/E move
- 8.3%
- Pseudo strike
- 45.83
- IV
- 82.1%
- B/E move
- 5.7%
50Δ
- Pseudo strike
- 47.03
- IV
- 85.7%
- B/E move
- 6.8%
- Pseudo strike
- 46.58
- IV
- 81.0%
- B/E move
- 5.0%
55Δ
- Pseudo strike
- 46.12
- IV
- 80.7%
- B/E move
- 5.3%
- Pseudo strike
- 47.34
- IV
- 79.9%
- B/E move
- 4.3%
60Δ
- Pseudo strike
- 45.20
- IV
- 75.6%
- B/E move
- 3.9%
- Pseudo strike
- 48.09
- IV
- 78.9%
- B/E move
- 3.6%
65Δ
- Pseudo strike
- 44.24
- IV
- 76.6%
- B/E move
- 3.1%
- Pseudo strike
- 48.85
- IV
- 77.8%
- B/E move
- 2.9%
70Δ
- Pseudo strike
- 43.26
- IV
- 79.3%
- B/E move
- 2.7%
- Pseudo strike
- 49.60
- IV
- 76.7%
- B/E move
- 2.2%
75Δ
- Pseudo strike
- 42.28
- IV
- 82.1%
- B/E move
- 2.2%
- Pseudo strike
- 50.53
- IV
- 75.1%
- B/E move
- 1.6%
80Δ
- Pseudo strike
- 41.29
- IV
- 84.8%
- B/E move
- 1.7%
- Pseudo strike
- 51.67
- IV
- 73.0%
- B/E move
- 1.2%
Options history
Table
| Date | IV (%) |
|---|---|
| 61.17% | |
| 61.85% | |
| 66.34% | |
| 68.30% | |
| 75.10% | |
| 56.43% | |
| 57.69% | |
| 56.98% | |
| 57.73% | |
| 57.74% | |
| 56.53% | |
| 58.73% | |
| 60.49% | |
| 58.51% | |
| 59.33% | |
| 57.48% | |
| 60.99% | |
| 67.70% | |
| 67.47% | |
| 65.89% | |
| 69.43% | |
| 70.95% | |
| 81.51% | |
| 63.37% | |
| 65.39% | |
| 66.61% | |
| 67.58% | |
| 67.31% | |
| 67.99% | |
| 68.02% | |
| 71.45% | |
| 69.33% | |
| 68.45% | |
| 73.08% | |
| 74.37% | |
| 74.26% | |
| 76.64% | |
| 71.98% | |
| 72.61% | |
| 79.63% | |
| 79.24% | |
| 67.36% | |
| 70.57% | |
| 68.77% | |
| 70.10% | |
| 69.60% | |
| 70.81% | |
| 73.08% | |
| 72.14% | |
| 73.90% | |
| 73.25% | |
| 75.54% |
Insurance Brokers
LIFE
aTyr Pharma, Inc., a clinical-stage biotherapeutics company, is dedicated to the discovery and development of drugs based on new immune pathways in the United States. The company…
More →MRSH
Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people…
More →NP
Neenah, Inc., a specialty materials company, produces and sells performance-based technical products and fine paper and packaging products worldwide. The company is headquartered…
More →RYAN
Ryan Specialty Group Holdings Inc is a leading provider of specialty insurance solutions, renowned for its innovative and tailored risk management services across various sectors.…
More →SLQT
Founded in 1985, SelectQuote (NYSE: SLQT) offers solutions that help consumers protect their most valuable assets - their families, health, and property.
More →TREE
Description unavailable
More →